Trevor Martin is the Co-Founder and CEO of Mammoth Biosciences, where he leads the development of the next generation of CRISPR-based products for therapeutics and diagnostics. A Stanford PhD and Princeton graduate, his work focuses on harnessing novel CRISPR systems to read and write the code of life, aiming to cure diseases.
Drawing from his time at Princeton, Trevor has a background in campus leadership, including participation in the Undergraduate Student Government and the Outdoor Action Freshman Camping Orientation Program. He has always been interested in the intersection of different fields, like biology, statistics, and computer science, which fueled his path through academia and entrepreneurship.
Trevor was featured on the Forbes "30 Under 30" list in Healthcare for his pioneering work in co-founding Mammoth Biosciences.
Read the full overview →They are always well-planned and adopt a systematic approach. They tend to be clear about their needs and limitations and are unlikely to promise too much. They do not like taking risks at all and go for proven options in the end.
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.